Evidence map›Paper›PMID 21735226›Full record

ArticleCurrent microbiology2011

Recognition of host proteins by Helicobacter cysteine-rich protein C.

Bernd Roschitzki, Stefan Schauer, Peer R E Mittl

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Live Attenuated Measles Virus Vaccine ExpressingMolecular therapy oncolytics · 2020
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Bernd RoschitzkiFunctional Genomics Center Zurich, UZH / ETH Zürich, Winterthurerstr. 190, 8057 Zürich, Switzerland. bernd.roschitzki@fgcz.uzh.ch
Stefan Schauer
Peer R E Mittl
University of Zurich · CHETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetratricopeptide- and sel1-like repeat (SLR) proteins modulate various cellular activities, ranging from transcription regulation to cell-fate control. Helicobacter cysteine-rich proteins (Hcp) consist of several SLRs that are cross-linked by disulfide bridges and have been implicated in host/pathogen interactions. Using pull-down proteomics, several human proteins including Nek9, Hsp90, and Hsc71 have been identified as putative human interaction partners for HcpC. The interaction between the NimA-like protein kinase Nek9 and HcpC has been validated by ELISA and surface plasmon resonance. Recombinant Nek9 is recognized by HcpC with a dissociation constant in the lower micromolar range. This interaction is formed either directly between Nek9 and HcpC or via the formation of a complex with Hsc71. The HcpC homologue HcpA possesses no affinity for Nek9, suggesting that the reported interaction is rather specific for HcpC. These results are consistent with previous observations where Nek9 was targeted upon bacterial or viral invasion. However, further experiments will be required to show that the reported interactions also occur in vivo.

Indexed as

Host-Pathogen InteractionsBacterial ProteinsEnzyme-Linked Immunosorbent AssayHelicobacter pyloriHSC70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHumansKineticsNIMA-Related KinasesProtein BindingProtein Serine-Threonine KinasesSurface Plasmon ResonanceVirulence FactorsBacterial ProteinsHSC70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHSPA8 protein, humanNEK9 protein, humanNIMA-Related KinasesProtein Serine-Threonine KinasesVirulence Factors

Identifiers

PMID21735226
OpenAlexW1981432540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.